Japanese company

Japan Bio Products (JBP) is a leading Japanese biopharmaceutical company specializing in the research, development, and manufacturing of placenta-derived products. Founded in 1970, the company is globally recognized for its flagship product, Laennec, an ethical pharmaceutical injection derived from human placenta used for improving liver function and treating various chronic conditions. JBP leverages advanced extraction and safety technologies to produce high-purity placental extracts for medical, cosmetic, and nutritional applications. The company operates a specialized research arm, RE Biotech, which focuses on next-generation regenerative medicine and extracellular vesicle research. With a strong emphasis on safety and scientific validation, JBP maintains a dominant position in the global placental therapeutics market.